Analyst Ratings for Agile Therapeutics (AGRX)
AGRX Rating Summary
AGRX Price Target Summary
- Highest: $925.00 (RBC Capital)
- Lowest: $925.00 (RBC Capital)
- Average: $925.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$925.00 (+61158.3%)
* Over Last 12-Mos
Rating Score: 7.5 / 10
Percentile Rank: 80%
Rating Score: 7.5 / 10
Percentile Rank: 80%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/18/2024 | Maxim Group | Naz Rahman | Downgrade | Hold (Buy) |
N/A (N/A) |
0.54 (1.51) |
179.63% | Details |
| 4/7/2021 | RBC Capital » Updated 12/17/2025 |
Daniel Busb | New Coverage | Outperform (N/A) |
925.00 (860.00) |
2.06 (1.51) |
-26.7% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
